Home
Conditions
Breast Neoplasms

Clinical trial condition

Breast Neoplasms

Explore clinical trials studying Breast Neoplasms. Study availability and eligibility vary by location and protocol.

608 public trials 216 recruiting studies

Refine in advanced search Browse all conditions

Breast Neoplasms trial results

Completed

Trial Comparing Radioactive Seed Localization to Standard Procedure for Non-palpable Breast Cancers

NCT00225927

Conditions: Breast Cancer Invasive Nos, Breast Carcinoma In Situ, Breast Diseases, +10 more
Locations: St. Joseph's Healthcare Hamilton, Ontario, Canada

Juravinski Cancer Centre Hamilton, Ontario, Canada

Princess Margaret Hospital Toronto, Ontario, Canada

View Trial Details

Completed

Establishing an Inflammatory Breast Cancer Registry

NCT00340158

Conditions: Aberrant Motor Behavior in Dementia, Aggression, Behavior, +13 more
Locations: National Cancer Institute (NCI), 9000 Rockville Pike Bethesda, Maryland, United States

View Trial Details

Active, Not Recruiting

Study of AB598 Monotherapy and Combination Therapy in Participants With Advanced Cancers

NCT05891171

Conditions: Adenocarcinoma, Adnexal Diseases, Advanced Cancer, +64 more
Locations: Research Site Phoenix, Arizona, United States

Research Site Jacksonville, Florida, United States

Research Site Lake City, Florida, United States

Research Site Hinsdale, Illinois, United States

View all 14 locations

View Trial Details

Active, Not Recruiting

Safety and Tolerability of IPH4502 in Patients With Advanced Solid Tumors

NCT06781983

Conditions: Adnexal Diseases, Advanced or Metastatic Solid Tumors, Breast Diseases, +64 more
Locations: Massachusetts General Hospital - Boston Boston, Massachusetts, United States

John Theurer Cancer Center Hackensack, New Jersey, United States

Mount Sinai Tisch Cancer Center New York, United States

NEXT Oncology - Dallas Dallas, Texas, United States

View Trial Details

Active, Not Recruiting

Atezolizumab Combined With BDB001 AnD Immunogenic Radiotherapy in Patients With Advanced Solid Tumors

NCT03915678

Conditions: Bladder Cancer, Breast Diseases, Breast Neoplasms, +45 more
Locations: Institut Bergonié Bordeaux, France

Chu Brest Brest, France

Centre François Baclesse Caen, France

Centre Georges François Leclerc Dijon, France

View Trial Details

Active, Not Recruiting

A Study Comparing BL-B01D1 With Chemotherapy of Physician's Choice in Patients With Unresectable Locally Advanced or Metastatic Triple-Negative Breast Cancer(PANKU-Breast02)

NCT06382142

Conditions: Breast Diseases, Breast Neoplasms, Neoplasms, +5 more
Locations: Fudan University Shanghai Cancer Center Shanghai, Shanghai Municipality, China

View Trial Details

Active, Not Recruiting

STEMVAC in Patients With Early Stage Triple Negative Breast Cancer

NCT05455658

Conditions: Anatomic Stage IB Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IIA Breast Cancer AJCC v8, +21 more
Locations: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States

Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States

University of Wisconsin Carbone Cancer Center Madison, Wisconsin, United States

View Trial Details

Active, Not Recruiting

MRI Characterization of Mammographically Detected DCIS

NCT03495011

Conditions: Adenocarcinoma, Breast Cancer, Stage 0, Breast Carcinoma In Situ, +12 more
Locations: Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States

View Trial Details

Active, Not Recruiting

Study Comparing the Standard Administration of IO Versus the Same IO Administered Each 3 Months in Patients in Response After 6 Months of Standard IO

NCT05078047

Conditions: Adenocarcinoma, Basal Cell Carcinoma, Breast Diseases, +69 more
Locations: Institut de cancérologie de l'Ouest Angers, France

Clinique Sainte Catherine Avignon, France

Centre Hospitalier de la Côte Basque Bayonne, France

CHU Bordeaux - Hôpial Saint André Bordeaux, France

View all 33 locations

View Trial Details

Active, Not Recruiting

Pembrolizumab in Treating Patients With Stage IV Metastatic or Recurrent Inflammatory Breast Cancer or Triple-Negative Breast Cancer Who Have Achieved Clinical Response or Stable Disease to Prior Chemotherapy

NCT02411656

Conditions: Breast Diseases, Breast Neoplasms, Edema, +17 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Breast Neoplasms

Breast Neoplasms trial results

Related conditions